Skip to main content
. 2019 Jul 4;12:1951–1967. doi: 10.2147/IDR.S178381

Figure 1.

Figure 1

Timeline of pivotal Phase III HPV vaccine trials and licensure/registration of the HPV vaccines.

Notes: aTwo-dose schedule separated by six months to adolescents aged <15 years. b Data from Iversen et al.57

Abbreviations: 4vHPV, quadrivalent HPV vaccine; 2vHPV, bivalent HPV vaccine; 9vHPV, nonavalent HPV vaccine; FDA, The U.S. Food and Drug Administration; HPV, human papillomavirus; EU, European Union; VLP, virus-like particle.